Fractalkine (CX3CL1) and Brain Inflammation: Implications for HIV-1-Associated Dementia

References

• Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, Dawson TM, Dawson VL (1996). Im-munologic NO synthase: elevation in severe AIDS de-mentia and induction by HIV-1 gp41. Science 274: 1917–1926.
   Google Scholar
• Albright AV, Shieh JT, Itoh T, Lee B, Pleasure D, O'connor MJ, Doms RW, Gonzalez-Scarano F (1999). Microglia ex-press CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J Virol 73: 205–213.
   PubMed Web of Science ®Google Scholar
• Alexander RW (2001). Cytokine receptor CX3CR-1 and fractalkine: new factors in the atherosclerosis drama? Circ Res 89: 376–377.
   Google Scholar
• Aquaro S, Panti S, Caroleo MC, Balestra E, Cenci A, Forbici F, Ippolito G, Mastino A, Testi R, Mollace V, et al (2000). Primary macrophages infected by human immunodefi-ciency virus trigger CD95-mediated apoptosis of unin-fected astrocytes. J Leukoc Biol 68: 429–435.
   PubMed Web of Science ®Google Scholar
• Asare E, Dunn G, Glass J, McArthur J, Luthert P, Lantos P, Everall 1(1996). Neuronal pattern correlates with the severity of human immunodeficiency virus-associated dementia complex. Am J Pathol 148: 31–38.
   Google Scholar
• Baggiolini M, Dewald B, Moser B (1997). Human chemokines: an update. Annu Rev Immunol 15: 675–705.
   PubMed Web of Science ®Google Scholar
• Bamea A, Aguila-Mansilla N, Chute HT, Welcher AA (1996). Comparison of neurotrophin regulation of hu-man and rat neuropeptide Y (NPY) neurons: induction of NPY production in aggregate cultures derived from rat but not from human fetal brains. Brain Res 732: 52–60.
   Google Scholar
• Batchelor PE, Liberatore GT, Wong JY, Porritt MJ, Frerichs F, Donnan GA, Howells DW (1999). Acti-vated macrophages and microglia induce dopaminer-gic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 19: 1708–1716.
   PubMed Web of Science ®Google Scholar
• Bazan J, Bacon K, Hardiman G, Wang W, Soo K, Rossi D, Greaves D, Zlotnik A, Schall T (1997). A new class of membrane-bound chemokine with a CX3C motif. Nature 385: 640–644.
   PubMed Web of Science ®Google Scholar
• Biber K, Sauter A, Brouwer N, Copray SC, Boddeke HW (2001). Ischemia-induced neuronal expression of the mi-croglia attracting chemokine secondary lymphoid-tissue chemokine (SLC). Glia 34: 121–133.
   Google Scholar
• Boehme SA, Lio FM, Maciejewski-Lenoir D, Bacon KB, Conlon PJ (2000). The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J Immunol 165: 397–403.
   PubMed Web of Science ®Google Scholar
• Broder CC, Collman RG (1997). Chemokine receptors and HIV. J Leukoc Biol 62: 20–29.
   PubMedGoogle Scholar
• Cambien B, Pomeranz M, Schmid-Antomarchi H, Millet MA, Breittrnayer V, Rossi B, Schmid-Alliana A (2001). Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood 97: 2031–2037.
   Google Scholar
• Caroleo MC, Costa N, Bracci-Laudiero L, Aloe L (2001). Human monocyte/macrophages activated by exposure to LPS overexpress NGF and NGF receptors. J Neuroim-munol 113: 193–201.
   Google Scholar
• Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, et al (2000). Antiretrovi-ral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA 283: 381–390.
   PubMed Web of Science ®Google Scholar
• Chao CC, Hu S, Sheng WS, Tsang M, Peterson PK (1995). Tumor necrosis factor-a mediates the release of bioactive transforming growth factor /3 in murine microglial cell cultures. Clin Immunol Immunopathol 77: 358–365.
   PubMedGoogle Scholar
• Chapman GA, Moores K, Harrison D, Campbell CA, Stewart BR, Strijbos PJ (2000a). Fractalkine cleavage from neu-ronal membranes represents an acute event in the in-flammatory response to excitotoxic brain damage. J Neu-rosci (Online) 20: RC87.
   Google Scholar
• Chapman GA, Moores KE, Gohil J, Berkhout TA, Patel L, Green P, Macphee CH, Stewart BR (2000b). The role of fractalkine in the recruitment of monocytes to the en-dothelium. Eur J Pharmacol 392: 189–195.
   Google Scholar
• Cockwell P, Chakravorty SJ, Girdlestone J, Savage CO (2002). Fractalkine expression in human renal inflam-mation. JPatho/ 196: 85–90.
   Google Scholar
• Combadiere C, Salzwedel K, Smith ED, Tiffany HL, Berger EA, Murphy PM (1998). Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1. J Biol Chem 273: 23799–23804.
   Google Scholar
• Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO (1998). Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Nati Acad Sci USA 95: 3117–3121.
   PubMed Web of Science ®Google Scholar
• Cook DN, Chen SC, Sullivan LM, Manfra DJ, Wiekowski MT, Prosser DM, Vassileva G, Lira SA (2001). Generation and analysis of mice lacking the chemokine fractalkine. Mol Cell Biol 21: 3159–3165.
   PubMed Web of Science ®Google Scholar
• Cotter R, Zheng J, Gendelman HE (1999a). The role of mononuclear phagocytes in neurodegenerative dis-orders: lessons from multiple sclerosis, Alzheimer's disease and HIV-1 dementia. In: Advances in neurode-generative disorders. Marwah J, Teitelbaum H (eds). Prominent Press: Scottsdale, AZ, pp 203–241.
   Google Scholar
• Cotter R, Zheng J, Niemann D, Thomas E, Gendelman H (1999b). CD4OL activation of mononuclear phagocytes: regulation of HIV-1 replication and beta-chemokine pro-duction. Paper presented at XIth International Congress of Virology, Interbational Union of Microbiological So-cieties, Sydney, Australia, August 9–13.
   Google Scholar
• Cotter RL, Zheng J, Che M, Niemann D, Liu Y, He J, Thomas E, Gendelman HE (2001). Regulation of human im-munodeficiency virus type 1 infection, beta chemokine production, and CCR5 expression in CD4OL-stimulated macrophages: immune control of viral entry. J Virol 75: 4308–4320.
   Google Scholar
• Coughlan CM, McManus CM, Sharron M, Gao Z, Murphy D, Jaffer S, Choe W, Chen W, Hesselgesser J, Gaylord H, et al (2000). Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons (In Process Citation]. Neuroscience 97: 591–600.
   Google Scholar
• Desbaillets I, Tada M, de Tribolet N, Diserens AC, Hamou MF, Van Meir EG (1994). Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int j Cancer 58: 240–247.
   PubMed Web of Science ®Google Scholar
• Deshmukh M, Vasilakos J, Deckwerth TL (1996). Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases. J Cell Biol 135: 1341–1354.
   PubMed Web of Science ®Google Scholar
• Devi LA (2000). G-protein-coupled receptor dimers in the lime light. Trends Pharmacol Sci 21: 324–326.
   Google Scholar
• Dichmann S, Herouy Y, Purlis D, Rheinen H, Gebicke-Harter P, Norgauer J (2001). Fractalkine induces chemo-taxis and actin polymerization in human dendritic cells. Inflamm Res 50: 529–533.
   PubMed Web of Science ®Google Scholar
• Dickson D, Lee S, Hatch W, Mattiace L, Brosnan C, Lyman W (1994). Macrophages and microglia in HIV-related CNS neuropathology. In: HIV, AIDS, and the brain. Price R, Perry S (eds). Raven: New York, pp 99–118.
   Google Scholar
• Dorf ME, Berman MA, Tanabe S, Heesen M, Luo Y (2000). Astrocytes express functional chemokine receptors. J Neuroimmunol 111: 109–121.
   Google Scholar
• Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA (1996). HIV-1 entry into CD4+ cells is me-diated by the chemokines receptor CC-CKR-5. Nature 381: 667–673.
   PubMed Web of Science ®Google Scholar
• Elkabes S, DiCicco-Bloom EM, Black IB (1996). Brain mi-croglia/macrophages express neurotrophins that selec-tively regulate microglial proliferation and function. J Neurosci 16: 2508–2521.
   PubMed Web of Science ®Google Scholar
• Endres MJ, Clapham PR, Marsh M, Ahuja M, Turner JD, McKnight A, Thomas JF, Stoebenau-Haggarty B, Choe S, Vance PJ, et al (1996). CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87: 745–756.
   PubMed Web of Science ®Google Scholar
• Faure S, Meyer L, Costagliola D, Vaneensberghe C, Genin E, Autran B, Delfraissy JF, McDermott DH, Murphy PM, Debre P, et al (2000). Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science 287: 2274–2277.
   PubMed Web of Science ®Google Scholar
• Feng L, Chen S, Garcia GE, Xia Y, Siani MA, Botti P, Wilson CB, Harrison JK, Bacon KB (1999). Prevention of cres-centic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication. Kidney Int 56: 612–620.
   PubMed Web of Science ®Google Scholar
• Fischer-Smith T, Croul S, Sverstiuk AE, Capini C, L'Heureux D, Regulier EG, Richardson MW, Amini S, Morgello S, Khalili K, Rappaport J (2001). CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reser-voir of HIV infection. J NeuroVirol 7: 528–541.
   PubMed Web of Science ®Google Scholar
• Fong AM, Erickson HP, Zachariah JP, Poon S, Schamberg NJ, Imai T, Patel DD (2000). Ultrastructure and func-tion of the fractalkine mucin domain in CX(3)C chemokine domain presentation. JBiol Chem 275: 3781–3786.
   Google Scholar
• Fong AM, Robinson LA, Steeber DA, Tedder TF, Yoshie O, Imai T, Patel DD (1998). Fractalkine and CX3CR1 medi-ate a novel mechanism of leukocyte capture, firm adhe-sion, and activation under physiologic flow. J Exp Med 188: 1413–1419.
   Google Scholar
• Foussat A, Bouchet-Delbos L, Berrebi D, Durand-Gasselin I, Coulomb-L'Hermine A, Krzysiek R, Galanaud P, Levy Y, Emilie D (2001). Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients. Blood 98: 1678–1686.
   Google Scholar
• Foussat A, Coulomb-L'Hermine A, Gosling J, Krzysiek R, Durand-Gasselin I, Schall T, Balian A, Richard Y, Galanaud P, Emilie D (2000). Fractalkine receptor ex-pression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur J Immunol 30: 87–97.
   Google Scholar
• Fraticelli P, Sironi M, Bianchi G, D'Ambrosio D, Albanesi C, Stoppacciaro A, Chieppa M, Allavena P, Ruco L, Girolomoni G, et al (2001). Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 107: 1173–1181.
   PubMed Web of Science ®Google Scholar
• Fujimoto K, Imaizumi T, Yoshida H, Takanashi S, Okumura K, Satoh K (2001). Interferon-gamma stimu-lates fractalkine expression in human bronchial epithe-lial cells and regulates mononuclear cell adherence. Am J Respir Cell Mol Biol 25: 233–238.
   Google Scholar
• Furuichi K, Wada T, Iwata Y, Sakai N, Yoshimoto K, Shimizu M, Kobayashi K, Takasawa K, Kida H, Takeda S, et al (2001). Upregulation of fractalkine in human cres-centic glomerulonephritis. Nephron 87: 314–320.
   PubMed Web of Science ®Google Scholar
• Gabuzda D, He J, Ohagen A, Vallat A (1998). Chemokine re-ceptors in HIV-1 infection of the central nervous system. /mmuno/ogy 10: 203–213.
   Google Scholar
• Gabuzda D, Wang J (1999). Chemokine receptors and virus entry in the central nervous system. J NeuroVirol 5: 643–658.
   Web of Science ®Google Scholar
• Gabuzda D, Wang J (2000). Chemokine receptors and mech-anisms of cell death in HIV neuropathogenesis. J Neuro-Virol 6 (Suppl 1): S24–S32.
   Google Scholar
• Gabuzda D, Wang J, Gorry P (2002). HIV-1-associated dementia. In: Chemokines and the nervous system. Ransohoff RM, Suzuki K, Proudfoot AEI, Hickey WF, Harrison JK (eds). Elsevier Science: Amsterdam, pp 345–360.
   Google Scholar
• Garaci E, Caroleo MC, Aloe L, Aquaro S, Piacentini M, Costa N, Amendola A, Micera A, Calio R, Perno CF, Levi-Montalcini R (1999). Nerve growth factor is an au-tocrine factor essential for the survival of macrophages infected with HIV. Proc Natl Acad Sci USA 96: 14013–14018.
   PubMed Web of Science ®Google Scholar
• Garcia GE, Xia Y, Chen S, Wang Y, Ye RD, Harrison JK, Bacon KB, Zerwes HG, Feng L (2000). NF-kappaB-dependent fractalkine induction in rat aortic endothe-lial cells stimulated by IL-1beta, TNF-alpha, and LPS. J Leukoc Biol 67: 577–584.
   Google Scholar
• Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ, Raines EW (2001). Tumor necro-sis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).JBiol Chem 276: 37993–38001.
   Google Scholar
• Gelbard H, Nottet H, Dzenko K, Jett M, Genis P, White R, Wang L, Choi Y-B, Zhang D, Lipton S, et al (1994). Platelet-activating factor: a candidate human immunod-eficiency virus type-1 infection neurotoxin. J Virol 68: 4628–4635.
   PubMed Web of Science ®Google Scholar
• Gelbard HA, Epstein LG (1995). HIV-1 encephalopathy in children. Curr Opin Pediatr 7: 655–662.
   PubMedGoogle Scholar
• Gendelman H, Persidsky Y, Ghorpade A, Limoges J, Stins M, Fiala M, Morrisett R (1997). The neuropathogenesis of AIDS dementia complex. AIDS 11: S35–S45.
   Google Scholar
• Gendelman HE (1997). The neuropathogenesis of HIV-1 dementia. In: The neurology of AIDS. Gendelman HE, Lipton SA, Epstein LG, Swindells S (eds). Chapman and Hall: New York, pp 1–10.
   Google Scholar
• Genis P, Jett M, Bernton E, Boyle T, Gelbard H, Dzenlco K, Keane R, Resnick L, Mizrachi Y, Volsky D, et al (1992). Cytokines and arachidonic metabolites pro-duced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implica-tions for the neuropathogenesis of HIV disease. J Exp Med 176: 1703–1718.
   Google Scholar
• Ghorpade A, Xia MQ, Hyman BT, Persidsky Y, Nukuna A, Bock P, Che M, Limoges J, Gendelman HE, Mackay CR (1998). Role of the /3-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infec-tion of monocytes and microglia. J Virol 72: 3351–3361.
   Google Scholar
• Giulian D, Noonan C, Vaca K (1990). HIV-1 infected mononuclear phagocytes release neurotoxins. Science 250: 1593–1595.
   PubMed Web of Science ®Google Scholar
• Giulian D, Yu J, Xia L, Tom D, Li J, Lin SN, Schwarz R, Noonan C (1996). Study of receptor-mediated neurotox-ins released by HIV-1 infected mononuclear phagocytes found in human brain. J Neurosci 16: 3139–3153.
   PubMed Web of Science ®Google Scholar
• Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995). Im-munocytochemical quantitation of human immunode-ficiency virus in the brain: correlations with dementia. Ann Neurol 38: 755–762.
   PubMed Web of Science ®Google Scholar
• Gleichmann M, Gillen C, Czardybon M, Bosse F, Greiner-Petter R, Auer J, Muller HW (2000). Cloning and char-acterization of SDF-1ga=a, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system. Eur j Neurosci 12: 1857–1866.
   PubMed Web of Science ®Google Scholar
• Goda S, Imai T, Yoshie O, Yoneda O, Inoue H, Nagano Y, Okazaki T, Imai H, Bloom ET, Domae N, Umehara H (2000). CX3C-chemokine, fractalkine-enhanced adhe-sion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms. I Immunol 164: 4313–4320.
   PubMed Web of Science ®Google Scholar
• Greaves DR, Hakkinen T, Lucas AD, Liddiard K, Jones E, Quinn CM, Senaratne J, Green FR, Tyson K, Boyle J, et al (2001). Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine are ex-pressed in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 21: 923–929.
   PubMed Web of Science ®Google Scholar
• Greaves DR, Gordon S (2001). Immunity, atherosclerosis and cardiovascular disease. Trends Immunol 22: 180–181.
   Google Scholar
• Harrison JK, Fong AM, Swain PA, Chen S, Yu YR, Salafranca MN, Greenleaf WB, Imai T, Patel DD (2001). Mutational analysis of the fractalkine chemokine do-main: basic amino acid residues differentially contribute to CX3CR1 binding, signaling, and cell adhesion. J Biol Chem 276: 8.
   Google Scholar
• Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, Streit, WJ, Salafranca MN, Adhikari S, Thompson DA, et al (1998). Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA 95: 10896–10901.
   PubMed Web of Science ®Google Scholar
• Haskell CA, Cleary MD, Charo IF (1999). Molecular uncou-pling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation. J Biol Chem 274: 10053–10058.
   Google Scholar
• Haskell CA, Cleary MD, Charo IF (2000). Unique role of the chemokine domain of fractalkine in cell capture. Kinet-ics of receptor dissociation correlate with cell adhesion. J Biol Chem 275: 34183–34189.
   Google Scholar
• Haskell CA, Hancock WW, Salant DJ, Gao W, Csizmadia V, Peters W, Faia K, Fituri O, Rottman JB, Charo IF (2001). Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection. J Clin Invest 108: 679–688.
   PubMedGoogle Scholar
• He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W, et al (1997). CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385: 645–649.
   PubMed Web of Science ®Google Scholar
• Hesselgesser J, Horuk R (1999). Chemokine and chemokine receptor expression in the central nervous system. J NeuroVirol 5: 13–26.
   PubMed Web of Science ®Google Scholar
• Heyes MP, Brew BB, Martin A, Price RW, Salazar A, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AE, Keilp J, et al (1991). Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurolog-ical status. Ann Neurol 29: 202–209.
   PubMed Web of Science ®Google Scholar
• Hoover DM, Mizoue LS, Handel TM, Lubkowski J (2000). The crystal structure of the chemokine domain of fractalkine shows a novel quaternary arrangement. JBiol Chem 275: 23187–23193.
   PubMed Web of Science ®Google Scholar
• Horuk R, Martin A, Hesselgesser J, Hadley T, Lu ZH, Wang ZX, Peiper SC (1996). The Duffy antigen receptor for chemokines: structural analysis and expression in the brain. JLeukoc Biol 59: 29–38.
   PubMed Web of Science ®Google Scholar
• Hughes PM, Botham MS, Frentzel S, Mir A, Perry VH (2002). Expression of fractalkine (CX3CL1) and its re-ceptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 37: 314–327.
   PubMed Web of Science ®Google Scholar
• Iismaa T, Biden T, Shine J (1995). G protein-coupled recep-tors. RG Landes: Austin, TX.
   Google Scholar
• Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ, Yoshie 0 (1997). Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91: 521–530.
   Google Scholar
• Imaizumi T, Matsumiya T, Fujimoto K, Okamoto K, Cui X, Ohtaki U, Hidemi Yoshida, Satoh K (2000). Interferon-gamma stimulates the expression of CX3CL1/fractalkine in cultured human endothelial cells. Tohoku J Exp Med 192: 127–139.
   PubMed Web of Science ®Google Scholar
• Inngjerdingen M, Damaj B, Maghazachi AA (2001). Expres-sion and regulation of chemokine receptors in human natural killer cells. Blood 97: 367–375.
   PubMed Web of Science ®Google Scholar
• Janssen R, Cornblath D, Epstein L, Foa R, McArthur J, Price R, Asbury A, Beckett A, Benson D, Bridge T, et al (1991). Nomenclature and research case definitions for neu-rological manifestations of human immunodeficiency virus type 1 (HIV-1) infection. Neurology 41: 778–785.
   PubMedGoogle Scholar
• Jiang Z, Piggee C, Heyes MP, Murphy C, Quearry B, Bauer M, Zheng J, Gendelman HE, Markey SP (2001). Glutamate is a mediator of neurotoxicity in secretions of activated HIV- 1-infected macrophages. J Neuroimmuno1117: 97–107.
   Google Scholar
• Jung S, Aliberti J, Grae=e1 P, Sunshine MJ, Kreutzberg GW, Sher A, Littman DR (2000). Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20: 4106–4114.
   PubMed Web of Science ®Google Scholar
• Kansra V, Groves C, Gutierrez-Ramos JC, Polakiewicz RD (2001). Phosphatidylinositol 3-kinase-dependent ex-tracellular calcium influx is essential for CX(3)CR1-mediated activation of the mitogen-activated protein ki-nase cascade. J Biol Chem 276: 31831–31838.
   Google Scholar
• Karpus WJ (2001). Chemokines and central nervous system disorders. J NeuroVirol 7: 493–500.
   Web of Science ®Google Scholar
• Kaul M, Lipton SA (1999). Chemokines and activated macrophages in HIV gp120-induced neuronal apopto-sis [In Process Citation]. Proc Natl Acad Sci USA 96: 8212–8216.
   PubMed Web of Science ®Google Scholar
• Kelder W, McArthur JC, Nance-Sproson T, McClernon D, Griffin DE (1998). /3-Chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of pa-tients with human immunodeficiency virus-associated dementia. Ann Neurol 44: 831–835.
   PubMed Web of Science ®Google Scholar
• Kerr SJ, Armati PJ, Guillemin GJ, Brew BJ (1998). Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia com-plex. AIDS 12: 355–363.
   PubMed Web of Science ®Google Scholar
• Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert VVE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, et al (1999). Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 189: 865–870.
   Google Scholar
• Kitai R, Zhao ML, Zhang N, Hua LL, Lee SC (2000). Role of MIP-1beta and RANTES in HIV-1 infection of microglia: inhibition of infection and induction by IFNbeta. J Neu-roimmunol 110: 230–239.
   PubMed Web of Science ®Google Scholar
• Klein R, Williams K, Alvarez-Hernandez X, Westmoreland S, Force T, Lackner A, Luster A (1999). Chemokine re-ceptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neu-ropathogenesis of AIDS. J Immunol 163: 1636–1646.
   PubMed Web of Science ®Google Scholar
• Koenig S, Gendelman HE, Orenstein JM, Canto MCD, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS (1986). Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233: 1089–1093.
   PubMed Web of Science ®Google Scholar
• Kornbluth RS, Kee K, Richman DD (1998). CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines. Proc Nati Acad Sci USA 95: 5205–5210.
   Google Scholar
• Krebs FC, Ross H, McAllister J, Wigdahl B (2000). HIV-1-associated central nervous system dysfunction. Adv Pharmacol 49: 315–385.
   Google Scholar
• Kullander K, Kylberg A, Ebendal T (1997). Specificity of neurotrophin-3 determined by loss-of-function mutage-nesis. Neurosci Res 50: 496–503.
   Google Scholar
• Kutsch O, Oh J, Nath A, Benveniste EN (2000). Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J Virol 74: 9214–9221.
   Google Scholar
• Lavi E, Strizki JM, Ulrich AM, Zhang W, Fu L, Wang Q, O'Connor M, Hoxie JA, Gonzalez-Scarano F (1997). CXCR-4 (fusin), a co-receptor for the type 1 human im-munodeficiency virus (HIV-1) is expressed in the human brain in a variety of cell types, including microglia and neurons. Am J Pathol 151: 1035–1042.
   PubMed Web of Science ®Google Scholar
• Letendre SL, Lanier ER, McCutchan JA (1999). Cere-brospinal fluid beta chemokine concentrations in neu-rocognitively impaired individuals infected with hu-man immunodeficiency virus type 1. J Infect Dis 180: 310–319.
   PubMed Web of Science ®Google Scholar
• Lopez A, Bauer MA, Erichsen DA, Peng H, Gendelman L, Shibata A, Gendelman HE, Zheng J (2001). The regula-tion of neurotrophic factor activities following HIV-1 in-fection and immune activation of mononuclear phago-cytes. Paper presented at the 31st Annual Meeting of the Society for Neuroscience, San Diego, California, November 10–15.
   Google Scholar
• Lopez-Ilasaca M (1998). Signaling from G-protein coupled receptors to mitogen activated protein (MAP) kinase cas-cades. Biochemical Pharmacol 56: 269–277.
   PubMed Web of Science ®Google Scholar
• Lopez-Illasaca M, Crespo P, Pellici PG, Gutkind JS, Wetzker R (1997). Linkage of G protein-coupled receptors to the MAPK signaling pathway through P13-kinase y. Science 275: 394–397.
   PubMedGoogle Scholar
• Loy R, Taglialatela G, Angelucci L, Heyer D, Perez-Polo R (1994). Regional CNS uptake of blood-borne nerve growth factor. J Neurosci Res 39: 339–346.
   Google Scholar
• Lucas AD, Chadwick N, Warren BF, Jewell DP, Gordon S, Powrie F, Greaves DR (2001). The transmembrane form of the CX3CL1 chemokine fractalkine is expressed pre-dominantly by epithelial cells in vivo. Am J Pathol 158: 855–866.
   PubMed Web of Science ®Google Scholar
• Luster AD (1998). Chemokines-chemotactic cytokines that mediate inflammation. N Engl j Med 338: 436–445.
   PubMed Web of Science ®Google Scholar
• Ma M, Geiger JD, Nath A (1994). Characterization of a novel binding site for the human immunodeficiency virus type 1 envelope protein gp120 on human fetal as-trocytes. J Virol 68: 6824–6828.
   PubMed Web of Science ®Google Scholar
• Maciejewski-Lenoir D, Chen S, Feng L, Maki R, Bacon KB (1999). Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J Immunol 163: 1628–1635.
   PubMed Web of Science ®Google Scholar
• Mackay CR (1996). Chemokine receptors and T cell chemo-taxis. J Exp Med 184: 799–802.
   PubMed Web of Science ®Google Scholar
• Mallat M, Houlgatte R, Brachet P, Prochiantz A (1989). Lipopolysaccharide-stimulated rat brain macrophages release NGF in vitro. Dev Biol 133: 309–311.
   PubMedGoogle Scholar
• Marder K, Albert S, Dooneief G, Stern Y, Ramachandran G, Epstein L (1996). Clinical confirmation of the american academy of neurology algorithm for HIV-1-associated cognitive/motor disorder. Neurology 47: 1247–1253.
   Google Scholar
• Masliah E (1996). In vivo modeling of HIV-1 mediated neu-rodegeneration. Am J Pathol 149: 745–750.
   Google Scholar
• Masliah E, DeTeresa RM, Mallory ME, Hansen LA (2000). Changes in pathological findings at autopsy in AIDS cases for the last 15 years. Aids 14: 69–74.
   PubMed Web of Science ®Google Scholar
• McArthur JC, Sacktor N, Selnes 0 (1999). Human immun-odeficiency virus-associated dementia. Semin Neurol 19: 129–150.
   Google Scholar
• McDermott DH, Halcox JP, Schenke WH, Waclawiw MA, Merrell MN, Epstein N, Quyyumi AA, Murphy PM (2001). Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular en-dothelial dysfunction and atherosclerosis. Circ Res 89: 401–407.
   PubMed Web of Science ®Google Scholar
• Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ (1998). Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci 95: 14500–14505.
   Google Scholar
• Meucci O, Fatatis A, Simen AA, Miller RJ (2000). Expres-sion of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci USA 97: 8075–8080.
   Google Scholar
• Miller RJ, Meucci 0 (1999). AIDS and the brain: is there a chemokine connection? Trends Neurosci 22: 471–479.
   Google Scholar
• Minami M, Satoh M (2000). Chemokines as mediators for intercellular communication in the brain (in Japanese). Nippon Yakurigaku Zasshi 115: 193–200.
   Google Scholar
• Miwa T, Furukawa S, Nakajima K, Furukawa Y, Kohsaka S (1997). Lipopolysaccharide enhances synthesis of brain-derived neurotrophic factor in cultured rat microglia. J Neurosci Res 50: 1023–1029.
   PubMed Web of Science ®Google Scholar
• Mizoue LS, Bazan JF, Johnson EC, Handel TM (1999). So-lution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1. Biochemistry 38: 1402–1414.
   PubMedGoogle Scholar
• Mizoue LS, Sullivan SK, King DS, Kledal TN, Schwartz TW, Bacon KB, Handel TM (2001). Molecular determi-nants of receptor binding and signaling by the CX3C chemokine fractalkine. J Biol Chem 276: 33906–33914.
   Google Scholar
• Mollace V, Nottet HS, Clayette P, Turco MC, Muscoli C, Salvemini D, Perno CF (2001). Oxidative stress and neu-roAIDS: triggers, modulators and novel antioxidants. Trends Neurosci 24: 411–416.
   PubMed Web of Science ®Google Scholar
• Moses AV, Bloom FE, Pauza CD, Nelson JA (1993). HIV in-fection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc Natl Acad Sci USA 90: 10474–10478.
   PubMed Web of Science ®Google Scholar
• Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T (1996). Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382: 635–638.
   PubMed Web of Science ®Google Scholar
• Nath A, Geiger J (1998). Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mecha-nisms. Prog Neurobiol 54: 19–33.
   PubMed Web of Science ®Google Scholar
• Nath A, Hartloper V, Furer M, Fowke KR (1995). Infec-tion of human fetal astrocytes with HIV-1: viral tropism and the role of cell to cell contact in viral transmission. J Neuropathol Exp Neurol 54: 320–330.
   PubMed Web of Science ®Google Scholar
• Navia BA, Cho ES, Petito CK, Price RW (1986). The AIDS dementia complex: II. Neuropathology. Ann Neurol 19: 525–535.
   Google Scholar
• Nishiyori A, Minami M, Ohtani Y, Takami S, Yamamoto J, Kawaguchi N, Kume T, Akaike A, Satoh M (1998). Local-ization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett 429: 167–172.
   Google Scholar
• Peng H, Huang Y, Erichsen D, Zheng J (2002). HIV-1 gp120 and SDF1-a inhibit neural progenitor cell proliferation: links to HIV-1 associated dementia. Paper presented at The 32rd Annual Meeting of Society for Neuroscience, Orlando, Florida, November 2–7.
   Google Scholar
• Pereira CF, Middel J, Jansen G, Verhoef J, Nottet HS (2001). Enhanced expression of fractalkine in HIV-1 associated dementia. J Neuroimmunol 115: 168–175.
   Google Scholar
• Pemo CF, Crowe SM, Kombluth RS (1997). A continuing enigma: the role of cells of macrophage lineage in the development of HIV disease. J Leukoc Biol 62: 1–3.
   Google Scholar
• Persidsky Y (1999). Model systems for studies of leukocyte migration across the blood-brain barrier. J NeuroVirol 5: 579–590.
   Web of Science ®Google Scholar
• Persidsky Y, Ghorpade A, Rasmussen J, Limoges J, Liu XJ, Stins M, Fiala M, Way D, Kim KS, Witte MH, et al (1999). Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human im-munodeficiency virus-1 encephalitis. Am J Pathol 155: 1599–1611.
   PubMed Web of Science ®Google Scholar
• Pulliam L, Herndier BG, Tang NM, McGrath MS (1991). Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neu-rochemical alterations in cultured human brains. J Clin Invest 87: 503–512.
   PubMedGoogle Scholar
• Ranki A, Nyberg M, Ovod V, Haltia M, Elovaara I, Raininko R, Haapasalo H, Krohn K (1995). Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 9: 1001–1008.
   PubMed Web of Science ®Google Scholar
• Ransohoff R (1997). Chemokines in neurological dis-ease models: correlation between chemokine expression patterns and inflammatory pathology. J Leukoc Biol 62: 645–652.
   Google Scholar
• Ransohoff RM (1998). Chemokines and CNS Inflammation. Neurotransm 14: 3–12.
   Google Scholar
• Rappaport J, Joseph J, Croul S, Alexander G, Del Valle L, Amini S, Khalili K (1999). Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J Leukoc Biol 65: 458–465.
   PubMed Web of Science ®Google Scholar
• Raychaudhuri SP, Jiang WY, Farber EM (2001). Cellu-lar localization of fractalkine at sites of inflammation: antigen-presenting cells in psoriasis express high levels of fractalkine. Br J Dermatol 144: 1105–1113.
   Google Scholar
• Rocamora N, Pascual M, Acsady L, Lecea LD, Freund TF (1996). Expression of NGF and NT3 mRNAs hippocam-pal intemeurons innervated by the GABAergic septo-hippocampal pathway. J Neurosci 16: 3991–4004.
   Google Scholar
• Ruth JH, Volin MV, Haines GK 3rd, Woodruff DC, Katschke KJ, Jr, Woods JM, Park CC, Morel JC, Koch AE (2001). Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum 44: 1568–1581.
   PubMed Web of Science ®Google Scholar
• Saad B, Constam D, Ortrnann R, Moos M, Fontana A, Schachner M (1991). Astrocyte-derived TGF-/32 and NGF differentially regulate neural recognition molecule expression by cultured astrocytes. J Cell Biol 115: 473–484.
   Google Scholar
• Sanders VJ, Pittman CA, White MG, Wang G, Wiley CA, Achim CL (1998). Chemokines and receptors in HIV en-cephalitis. AIDS 12: 1021–1026.
   PubMed Web of Science ®Google Scholar
• Schwaeble WJ, Stover CM, Schall TJ, Dairaghi DJ, Trinder PK, Linington C, Iglesias A, Schubart A, Lynch NJ, Weihe E, Schafer MK (1998). Neuronal expression of fractalkine in the presence and absence of inflammation. FEBS Lett 439: 203–207.
   PubMedGoogle Scholar
• Sebire G, Emilie D, Wallon C, Hery C, Devergne O, Delfraissy J-F, Galanaud P, Tardieu M (1993). In vitro production of IL-6, IL-1/3, and tumor necrosis factor-a by human embryonic microglial and neural cells. J Im-muno1150: 1517–1523.
   Google Scholar
• Shieh JTC, Albright AV, Sharron M, Gartner S, Strizki J, Doms RW, Gonzalez-Scarano F (1998). Chemokine receptor utilization by human immundeficiency virus type 1 isolates that replicate in microglia. J Virol 72: 4243–4249.
   PubMed Web of Science ®Google Scholar
• Strizki JM, Albright AV, Sheng H, O'Connor M, Perrin L, Gonzalez-Scarano F (1996). Infection of primary human microglia and monocyte-derived macrophages with hu-man immunodeficiency virus type 1 isolates: evidence of differential tropism. J Virol 70: 7654–7662.
   PubMedGoogle Scholar
• Tong N, Perry SW, Zhang Q, James HJ, Guo H, Brooks A, Bal H, Kinnear SA, Fine S, Epstein LG, et al (2000). Neu-ronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J Immunol 164: 1333–1339.
   PubMed Web of Science ®Google Scholar
• Tornatore C, Nath A, Amemiya K, Major EO (1991). Per-sistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol 65: 6094–6100.
   PubMed Web of Science ®Google Scholar
• Tsou CL, Haskell CA, Charo IF (2001). Tumor necro-sis factor-alpha-converting enzyme mediates the in-ducible cleavage of fractalkine. J Biol Chem 276: 44622–44626.
   PubMed Web of Science ®Google Scholar
• Vallat A-V, Girolami UD, He J, Mhashikar A, Marasco W, Shi B, Gray F, Bell J, Keohane C, Smith TW, Gabuzda D (1998). Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol 152: 167–178.
   PubMed Web of Science ®Google Scholar
• van der Meer P, Ulrich AM, Gonzalez-Scarano F, Lavi E (2000). Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mech-anisms for HIV dementia. Exp Mol Pathol 69: 192–201.
   PubMed Web of Science ®Google Scholar
• Vicenzi E, Alfano M, Ghezzi S, Gatti A, Veglia F, Lazzarin A, Sozzani S, Mantovani A, Poli G (2000). Divergent reg-ulation of HIV-1 replication in PBMC of infected indi-viduals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1. J Leukoc Biol 68: 405–412.
   PubMed Web of Science ®Google Scholar
• Volin MV, Woods JM, Amin MA, Connors MA, Harlow LA, Koch AE (2001). Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis. Am J Pathol 159: 1521–1530.
   PubMed Web of Science ®Google Scholar
• Wiley CA (1995). Quantitative neuropathologic assessment of HIV-1 encephalitis. Curr Top Microbiol Immunol 202: 55–61.
   PubMed Web of Science ®Google Scholar
• Wiley CA, Achim C (1994). Human immunodeficiency virus encephalitis is the pathological correlate of de-mentia in acquired immunodeficiency syndrome. Ann Neurol 36: 673–676.
   PubMedGoogle Scholar
• Wiley CA, Masliah E, Morey M, Lemere C, Teresa R, Grafe M, Hansen L, Terry R (1991). Neocortical damage during HIV infection. Ann Neurol 29: 651–657.
   PubMed Web of Science ®Google Scholar
• Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MBA (1986). Cellular localization of human immunod-eficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Nati Acad Sci USA 83: 7089–7093.
   PubMed Web of Science ®Google Scholar
• Wu DT, Woodman SE, Weiss JM, McManus CM, D'Aversa TG, Hesselgesser J, Major EO, Nath A, Berman JW (2000). Mechanisms of leukocyte trafficking into the CNS.J Neu-TOViT016\(Suppl 1): S82–S85.
   Google Scholar
• Yoshida H, Imaizumi T, Fujimoto K, Matsuo N, Kimura K, Cui X, Matsumiya T, Tanji K, Shibata T, Tamo W, et al (2001). Synergistic stimulation, by tumor necro-sis factor-alpha and interferon-gamma, of fractalkine ex-pression in human astrocytes. Neurosci Lett 303: 132–136.
   PubMed Web of Science ®Google Scholar
• Zheng J, Bauer M, Cotter RL, Ryan LA, Lopez A, Williams C, Ghorpade A, Gendelman HE (2000). Fractalkine me-diated macrophage activation by neuronal injury: rele-vance for HIV-1 associated dementia. Paper presented at The 30th Annual Meeting of Society for Neuroscience, New Orleans, Louisiana, November 4–9.
   Google Scholar
• Zheng J, Gendelman HE (1997). The HIV-1 associated de-mentia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr Opin Neurol 10: 319–325.
   PubMed Web of Science ®Google Scholar
• Zheng J, Lopez A, Erichsen D, Peng H, Bauer M, Williams C, Morgello S, Ghorpade A, Gendelman HE, Cotter RL, Ryan LA (2002). Neuronal fractalkine: regulation of macrophage activation and inflammatory factor pro-duction during HIV-1 associated dementia. J Immunol Submitted.
   Google Scholar
• Zheng J, Niemann D, Bauer M, Williams C, Lopez A, Erichsen D, Ryan LA, Cotter RL, Ghorpade A, Swindells S, Gendelman HE (2001). HIV-1 glia interactions in interleukin-8 and growth-related oncogene a secretion, neuronal signaling and demise: relevance for HIV-1-associated dementia. Paper presented at The 8th Conference on Retroviruses and Opportunistic Infec-tions, Foundation for Retrovirology and Human Health, Chicago, Illinois, February 4–8.
   Google Scholar
• Zheng J, Thylin M, Ghorpade A, Xiong H, Persidsky Y, Cotter R, Niemann D, Che M, Zeng Y, Gelbard H, et al (1999). Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J Neuroimmunol 98: 185–200.
   PubMed Web of Science ®Google Scholar
• Zlotnik A, Yoshie 0 (2000). Chemokines: a new classifica-tion system and their role in immunity. Immunity 12: 121–127.
   PubMed Web of Science ®Google Scholar
• Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR (1998). Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393: 595–599.
   PubMed Web of Science ®Google Scholar
• Zujovic V, Benavides J, Vige X, Carter C, Taupin V (2000). Fractalkine modulates TNF-alpha secretion and neuro-toxicity induced by microglial activation [In Process Citation]. Glia 29: 305–315.
   Google Scholar